Companies / Annovis Bio, Inc.

Annovis Bio, Inc.

NYSE: ANVSCIK 1477845MALVERN, PA
Insider flow · last 90 daysNet buys $138.3K

Financials · FY2025

Revenue$0
Net income$-28.85M
Total debt
Cash$14.22M
Diluted EPS$-1.40
Shares outstanding34.6M

Ownership

34.6M shares outstanding · as of May 15, 2026
9.7%Insiders
Ownership
Insiders9.71%3,364,883
Institutions15.62%5,413,277
Public float74.66%25,868,708

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
9.71%3,364,883

Institutional holders 58

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Marshall Wace, LLP
13F manager
AddCommon Stock$1.03M+462K
+63.60%
1,187,499
3.43% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
NewCommon Stock$775.1K+348K
347,600
1.00% of shares
low
Q1 2026
as of
D.a. Davidson & Co.
13F manager
ExitCommon Stock$-556.3K-161K
-100.00%
0
low
Q1 2026
as of
OMERS Administration Corporation
13F manager
ExitCommon Stock$-214.9K-62K
-100.00%
0
low
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$205.2K+110K
+79.07%
249,856
0.72% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon Stock$169.1K+76K
+13.74%
627,659
1.81% of shares
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
NewCommon Stock$169.0K+91K
90,884
0.26% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$56.6K+25K
+11.43%
247,513
0.71% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ANVSCommon StockEquity03615A108BBG00PN9XD40